FIELD: medicine.
SUBSTANCE: method involves carrying out test with adrenocorticotropic. Blood levels of 11-desoxycortisol (S), cortisol (F), cortisone (E) and corticosterone (B) are determined by means of high performance liquid chromatography. Ratios of cortisol-to-cortisone levels (F/E) and to 11-desoxycortisol level (F/S) are calculated. Corticosterone level being lower than 17 ng/l and 11-desoxycortisol level being greater than 7.0 ng/l with F/E<5 and F/S<16, obliterated form of congenital adrenal gland cortex hyperplasia is to be diagnosed.
EFFECT: high accuracy of diagnosis.
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR DIAGNOSING OBLITERATED FORMS OF CONGENITAL SUPRARENAL GLAND CORTEX HYPERPLASIA | 2004 |
|
RU2261447C1 |
| METHOD FOR SIMULTANEOUS DIAGNOSIS OF NONCLASSICAL FORMS OF CONGENITAL ADRENAL CORTEX DYSFUNCTION WITH 21-HYDROXYLASE DEFICIENCY AND 11β-HYDROXYLASE | 2016 |
|
RU2649801C1 |
| METHOD FOR DIFFERENTIAL DIAGNOSIS OF ADRENAL GROWTHS | 2015 |
|
RU2583918C1 |
| METHOD FOR DIFFERENTIAL DIAGNOSIS OF OVARIAN AND ADRENAL HYPERANDROGENISM IN GIRLS OF PUBERTY AGE | 2015 |
|
RU2592235C1 |
| CFR RECEPTOR ANTAGONISTS FOR TREATMENT OF CONGENITAL ADRENAL HYPERPLASIA | 2015 |
|
RU2812318C2 |
| METHOD FOR ESTIMATING ADRENAL FUNCTION | 2011 |
|
RU2466410C2 |
| METHOD OF TREATMENT OF CHRONIC GESTATION NONBEARING AT ADRENAL DISEASE | 1993 |
|
RU2089203C1 |
| CFR RECEPTOR ANTAGONISTS FOR TREATING CONGENITAL ADRENAL HYPERPLASIA | 2015 |
|
RU2718918C2 |
| APPLICATION OF AGENT WITH MODIFYING PROPERTIES IN RELATION TO HORMONES OF ADRENAL GLANDS | 2011 |
|
RU2598708C2 |
| COMBINATION OF SOMATOSTATIN ANALOGUES WITH 11β-HYDROXYLASE INHIBITORS | 2013 |
|
RU2663455C2 |
